GMP Synthase Antikörper (AA 21-671)
Kurzübersicht für GMP Synthase Antikörper (AA 21-671) (ABIN7872180)
Target
Alle GMP Synthase (GMPS) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 21-671
-
Verwendungszweck
- GMP Synthase Antibody / GMPS
-
Aufreinigung
- Affinity purified
-
Immunogen
- A human recombinant partial protein (amino acids H21-K671) was used as the immunogen for the GMP Synthase antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the GMP Synthase antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the GMP Synthase antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- GMP Synthase (GMPS) (Guanine Monophosphate Synthetase (GMPS))
-
Andere Bezeichnung
- GMP Synthase
-
Hintergrund
- Guanosine monophosphate synthetase, also known as GMPS is an enzyme that converts xanthosine monophosphate to guanosine monophosphate. In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP.
-
UniProt
- P49915
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-